MEI Pharma (MEIP) SEC Filings & 10K Form $4.79 -0.04 (-0.83%) Closing price 08/12/2025 04:00 PM EasternExtended Trading$5.04 +0.25 (+5.22%) As of 04:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Recent MEI Pharma SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel DateFilerForm TypeView08/05/20257:05 AMMEI Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/30/20253:40 PMMEI Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/29/20254:23 PMCITADEL ADVISORS LLC (Filed by)MEI Pharma (Subject)Form SCHEDULE 13G07/28/20256:20 PMAnson Funds Management LP (Reporting)MEI Pharma (Subject)Form 144Notice of proposed sale of securities pursuant to Rule 144 07/23/20256:18 PMFunicular Funds, LP (Reporting)MEI Pharma (Subject)Form 144Notice of proposed sale of securities pursuant to Rule 144 07/22/20254:22 PMMEI Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/17/20258:33 PMDRISCOLL FREDERICK W (Reporting)MEI Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 07/17/20258:36 PMFile Justin J. (Reporting)MEI Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 07/17/20258:36 PMFlynn James P (Reporting)MEI Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 07/17/20258:38 PMGlover Nicholas (Reporting)MEI Pharma (Issuer)Form 4Statement of changes in beneficial ownership of securities 07/17/20258:39 PMMEI Pharma (Issuer)Reynolds Thomas C (Reporting)Form 4Statement of changes in beneficial ownership of securities 07/17/20258:40 PMMEI Pharma (Issuer)Wood Steven D (Reporting)Form 4Statement of changes in beneficial ownership of securities 03/07/20253:30 PMMEI Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/20/20244:10 PMMEI Pharma (Filer)Form DEF 14A12/20/20244:15 PMMEI Pharma (Filer)Form DEFA14A12/20/20244:20 PMMEI Pharma (Filer)Form ARS09/19/20244:20 PMMEI Pharma (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 09/19/20244:05 PMMEI Pharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies ZVRA SEC Filings ABUS SEC Filings GHRS SEC Filings SIGA SEC Filings MGTX SEC Filings DAWN SEC Filings AUTL SEC Filings KALV SEC Filings AVBP SEC Filings DNTH SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:MEIP) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MEI Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MEI Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access